Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pulmonx Corp
(NQ:
LUNG
)
6.420
+0.220 (+3.55%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pulmonx Corp
< Previous
1
2
Next >
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
November 19, 2024
From
Pulmonx Corporation
Via
Business Wire
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 07, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Present at the Stifel 2024 Healthcare Conference
November 05, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Reports Third Quarter 2024 Financial Results
October 30, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
October 16, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
September 09, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
August 29, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
August 22, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Reports Second Quarter 2024 Financial Results
July 31, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
July 29, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
July 10, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 06, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Reports First Quarter 2024 Financial Results
May 01, 2024
Achieves 30% year-over-year worldwide revenue growth
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
April 10, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
April 02, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
February 26, 2024
From
Pulmonx Corporation
Via
Business Wire
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
February 21, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
February 07, 2024
From
Pulmonx Corporation
Via
GlobeNewswire
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
December 11, 2023
From
The Honest Company, Inc.
Via
GlobeNewswire
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
November 15, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Participate at Upcoming Investor Conferences
October 31, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Reports Record Third Quarter 2023 Financial Results
October 30, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
October 16, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
October 10, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Participate at Upcoming Investor Conferences
August 30, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
Pulmonx Corporation
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
